These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 33251778)

  • 1. Combination Therapy by Tissue-Specific Suicide Gene and Bevacizumab in Intramedullary Spinal Cord Tumor.
    Gwak SJ; Che L; Yun Y; Lee M; Ha Y
    Yonsei Med J; 2020 Dec; 61(12):1042-1049. PubMed ID: 33251778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of hypoxia and glioma dual-specific suicide gene using dexamethasone conjugated polyethylenimine for glioblastoma-specific gene therapy.
    Kim HA; Park JH; Yi N; Lee M
    Mol Pharm; 2014 Mar; 11(3):938-50. PubMed ID: 24467192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducible Poly(Oligo-D-Arginine) as an Efficient Carrier of the Thymidine Kinase Gene in the Intracranial Glioblastoma Animal Model.
    Kim HA; Lee HL; Choi E; Kim YH; Lee M
    J Pharm Sci; 2015 Nov; 104(11):3743-3751. PubMed ID: 26178805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide micelle-mediated delivery of tissue-specific suicide gene and combined therapy with avastin in a glioblastoma model.
    Oh B; Han J; Choi E; Tan X; Lee M
    J Pharm Sci; 2015 Apr; 104(4):1461-9. PubMed ID: 25631673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of combined bevacizumab and temozolomide treatment on intramedullary spinal cord tumor.
    Gwak SJ; An SS; Yang MS; Joe E; Kim DH; Yoon DH; Kim KN; Ha Y
    Spine (Phila Pa 1976); 2014 Jan; 39(2):E65-73. PubMed ID: 24158177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model.
    Choi UH; Ha Y; Huang X; Park SR; Chung J; Hyun DK; Park H; Park HC; Kim SW; Lee M
    J Neurosurg Spine; 2007 Jul; 7(1):54-60. PubMed ID: 17633488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Treatment of Experimental Spinal Cord Glioma With Dual Gene-Engineered Human Neural Stem Cells.
    Ropper AE; Zeng X; Haragopal H; Anderson JE; Aljuboori Z; Han I; Abd-El-Barr M; Lee HJ; Sidman RL; Snyder EY; Viapiano MS; Kim SU; Chi JH; Teng YD
    Neurosurgery; 2016 Sep; 79(3):481-91. PubMed ID: 26671631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel model of intramedullary spinal cord tumors in rats: functional progression and histopathological characterization.
    Caplan J; Pradilla G; Hdeib A; Tyler BM; Legnani FG; Bagley CA; Brem H; Jallo G
    Neurosurgery; 2006 Jul; 59(1):193-200; discussion 193-200. PubMed ID: 16823316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal model of intramedullary spinal cord glioma using human glioblastoma multiforme neurospheres.
    Hsu W; Siu IM; Pradilla G; Gokaslan ZL; Jallo GI; Gallia GL
    J Neurosurg Spine; 2012 Mar; 16(3):315-9. PubMed ID: 22195609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular ablation of tumor blood vessels inhibits therapeutic effects of radiation and bevacizumab.
    Yadav VN; Altshuler D; Kadiyala P; Zamler D; Comba A; Appelman H; Dunn P; Koschmann C; Castro MG; Löwenstein PR
    Neuro Oncol; 2018 Sep; 20(10):1356-1367. PubMed ID: 29660022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suicide gene therapy using reducible poly (oligo-D-arginine) for the treatment of spinal cord tumors.
    Won YW; Kim KM; An SS; Lee M; Ha Y; Kim YH
    Biomaterials; 2011 Dec; 32(36):9766-75. PubMed ID: 21924768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral-Induced Spinal Cord Gliomas in Rat Model.
    Nagarajan PP; Tora MS; Neill SG; Federici T; Texakalidis P; Donsante A; Canoll P; Lei K; Boulis NM
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reproducible model of intramedullary spinal cord tumor in rats bearing RG2 cells.
    Zhuang Y; Zhao W; Zhang W; Wei H; Huang X; Cai G; Fu C; Wang C; Wang R; Shi S; Yang W; Chen C
    Oncotarget; 2017 May; 8(19):30971-30977. PubMed ID: 28415681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of Hypoxia-Inducible Heme Oxygenase-1 Gene for Site-Specific Gene Therapy in the Ischemic Stroke Animal Model.
    Choi M; Oh J; Rhim T; Lee M
    Pharm Res; 2016 Sep; 33(9):2250-8. PubMed ID: 27324961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
    Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
    Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemic injury-specific gene expression in the rat spinal cord injury model using hypoxia-inducible system.
    Lee M; Lee ES; Kim YS; Choi BH; Park SR; Park HS; Park HC; Kim SW; Ha Y
    Spine (Phila Pa 1976); 2005 Dec; 30(24):2729-34. PubMed ID: 16371895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy with an erythropoietin enhancer-mediated, hypoxia-inducible gene expression system in the corpus cavernosum of mice with high-cholesterol diet-induced erectile dysfunction.
    Ryu JK; Lee M; Choi MJ; Kim HA; Jin HR; Kim WJ; Yin GN; Song KM; Kwon MH; Suh JK
    J Androl; 2012; 33(5):845-53. PubMed ID: 22403284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of neural stem cells modified with hypoxia/neuron-specific VEGF expression system for spinal cord injury.
    Yun Y; Oh J; Kim Y; Kim G; Lee M; Ha Y
    Gene Ther; 2018 Jan; 25(1):27-38. PubMed ID: 29155421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury.
    Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M
    Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapy.
    Lee M; Choi D; Choi MJ; Jeong JH; Kim WJ; Oh S; Kim YH; Bull DA; Kim SW
    J Control Release; 2006 Sep; 115(1):113-9. PubMed ID: 16962197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.